KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Pharmaceuticals (ACAD) Times Interest Earned (2018 - 2019)

Acadia Pharmaceuticals has reported Times Interest Earned over the past 2 years, most recently at -$4757.6 for Q2 2019.

  • Quarterly results put Times Interest Earned at -$4757.6 for Q2 2019, down 1733.87% from a year ago — trailing twelve months through Mar 2020 was -$4270.5 (down 10413.52% YoY), and the annual figure for FY2018 was -$27.84, changed.
  • Times Interest Earned for Q2 2019 was -$4757.6 at Acadia Pharmaceuticals, down from -$382.68 in the prior quarter.
  • Over the last five years, Times Interest Earned for ACAD hit a ceiling of -$35.62 in Q3 2018 and a floor of -$4757.6 in Q2 2019.